title: [Experience with the thrombolytic therapy of myocardial infarct].
authors.forename: A L
authors.initials: AL
authors.lastname: Gospodarenko
authors.forename: V N
authors.initials: VN
authors.lastname: Ardashev
authors.forename: V P
authors.initials: VP
authors.lastname: Tiurin
authors.forename: V A
authors.initials: VA
authors.lastname: Chernetsov
authors.forename: V B
authors.initials: VB
authors.lastname: Iakovlev
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Vrublevskiĭ
authors.forename: A S
authors.initials: AS
authors.lastname: Makarenko
authors.forename: N V
authors.initials: NV
authors.lastname: Sokolianskiĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Chernov
authors.forename: V V
authors.initials: VV
authors.lastname: Kucherov
authors.forename: T A
authors.initials: TA
authors.lastname: Davrent'eva
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004562:Electrocardiography / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008889:Military Personnel; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D012426:Russia; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
vernacular_title: Opyt tromboliticheskoĭ terapii infarkta miokarda.